Shares of GW Pharmaceuticals (NASDAQ: GWPH) have gained 72% in the year-to-date period, emerging as a new favorite among pot investors. However,
Cronos Group Inc.
-(CRON)
XNAS:CRON
Cronos Group starts off fiscal 2019 with a profit in Q1
In the first quarter of 2019, Cronos Group (NASDAQ: CRON) more-than-doubled its revenues to C$6.5 million, primarily driven by the launch of the
Earnings preview: ‘Joint’ venture with Altria to help Cronos Group in Q1
Come Thursday and Cronos Group (NASDAQ: CRON) officially kicks off another season of cannabis stock earnings. The Toronto-based marijuana firm is scheduled
Calendar: Earnings of AIG, Electronic Arts, Walt Disney, Cronos Group, Dropbox, GoPro in lineup
AIG, Electronic Arts, Walt Disney, Cronos Group, Dropbox, GoPro, and more earnings are scheduled for the week between May 6 and 10.
Marijuana vs US: Will Aurora Cannabis survive in the banned market?
In the US, marijuana has been slowly turning to be legal in certain states but it still remained banned at the federal
Weed Earnings: Cronos Group misses estimates despite massive Q4 revenue growth
Cannabis giant Cronos Group (CRON) reported its fourth-quarter 2018 earnings on March 26, Tuesday, before the opening bell. This was the first
Calendar: Earnings of Red Hat, Cronos, KB Home, Accenture on queue
On the economic front, the US Commerce Department is expected to release its fourth-quarter gross domestic product on March 28 and the
Cronos Group earnings preview: All eyes on Altria partnership
Cannabis giant Cronos Group (CRON) is scheduled to report fourth-quarter earnings on March 26, Tuesday, before the opening bell. Q4 results pose
Tilray posts wider-than-expected Q4 loss
Tilray (TLRY) reported a wider loss in the fourth quarter due to higher operating costs and expenses. For surviving the rising competition
Investing in pot stocks 101: Here’s what you should know
Marijuana-based stocks are all the rage in the market now. They have even managed to hog the limelight from heavyweight gaming stocks
Q3 Earnings Preview: Canopy Growth likely to continue its recent bullish momentum
Canopy Growth (TSX: WEED, NYSE: CGC) will release its financial results for the third fiscal quarter of 2019 after the markets close
Key comments from Aurora Cannabis (ACB) Q2 2019 earnings conference call
Aurora Cannabis (ACB) on Monday reported a loss of C$238 million in the second quarter of 2019, compared to a profit of
Aurora Cannabis reports a loss of C$238 million for Q2
After a long delay, Aurora Cannabis (ACB) reported its second quarter 2019 results. The company reported a loss of C$238 million compared to
Altria’s shares gain after Q4 results match expectations
Altria Group Inc. (MO) reported revenue and earnings in line with consensus estimates for the fourth quarter of 2018. Shares were up
Tilray inks third deal in less than a month, this time with Authentic Brands Group
In its third deal in less than 30 days, Canadian licensed producer Tilray (TLRY) on Tuesday announced a partnership with brand management
Despite headwinds sin stocks look solid in 2019
There is no denying the fact that the sin industry – comprising cannabis, tobacco, alcohol and gambling sectors – is relatively undeterred
The cannabis industry is high on deals and partnerships
The marijuana industry may be a relative newbie in the stock markets, but that isn’t stopping it from going on a deal
Altria announces minority stake in JUUL and cost reduction plans
Altria Group Inc. (MO) acquired a 35% stake in e-cigarette company JUUL Labs Inc. (JUUL) through a $12.8 billion investment that values
Deal Alert: Altria Group buys mammoth stake in Canadian cannabis giant Cronos Group
Phillip Morris-parent Altria Group, Inc. (MO) today announced a deal to invest CAD 2.4 billion (about $1.8 billion) in Toronto-based cannabis giant
Despite uncertainties, cannabis firms emerge as top takeover targets
In all probability, 2019 will be the year of cannabis as far as Wall Street is concerned. After the beverages and healthcare
Cronos reports loss in 3Q despite strong revenue growth
Cannabis producer Cronos Group (CRON) revenues jumped 186% to CAD3.76 million for the third quarter 2018, aided by strong sales growth of